{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:00:47Z","timestamp":1784775647562,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002790","name":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["517504"],"award-info":[{"award-number":["517504"]}],"id":[{"id":"10.13039\/501100002790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002790","name":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["481502654"],"award-info":[{"award-number":["481502654"]}],"id":[{"id":"10.13039\/501100002790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74025-9","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:15:52Z","timestamp":1780438552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An agent-based platform for simulating the impact of chlamydia vaccine in the US population"],"prefix":"10.1038","volume":"17","author":[{"given":"Qi","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Ranson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8409-868X","authenticated-orcid":false,"given":"Nicola Luigi","family":"Bragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie Bosch","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Thommes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0052-5336","authenticated-orcid":false,"given":"Jianhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"74025_CR1","unstructured":"Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022\u20132030. (2024)."},{"key":"74025_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/OLQ.0b013e31815e41a3","volume":"35","author":"RC Brunham","year":"2008","unstructured":"Brunham, R. C. & Rekart, M. L. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex. Transm. Dis. 35, 53 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"74025_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/cid\/ciab1022","volume":"75","author":"CM Khosropour","year":"2022","unstructured":"Khosropour, C. M., Soge, O. O., Golden, M. R., Hughes, J. P. & Barbee, L. A. Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men. Clin. Infect. Dis. 75, 875\u2013881 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"74025_CR4","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/cid\/ciab680","volume":"74","author":"LA Barbee","year":"2021","unstructured":"Barbee, L. A. et al. The Natural history of rectal gonococcal and chlamydial infections: the ExGen study. Clin. Infect. Dis. 74, 1549\u20131556 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"74025_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/QCO.0000000000000804","volume":"35","author":"A Lau","year":"2022","unstructured":"Lau, A., Hocking, J. S. & Kong, F. Y. S. Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines. Curr. Opin. Infect. Dis. 35, 42\u201348 (2022).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"74025_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/OLQ.0000000000001157","volume":"47","author":"ER Learner","year":"2020","unstructured":"Learner, E. R. et al. The influence of screening, misclassification, and reporting biases on reported chlamydia case rates among young women in the United States, 2000 through 2017. Sex. Transm. Dis. 47, 369\u2013375 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"74025_CR7","unstructured":"STI screening recommendations. https:\/\/www.cdc.gov\/std\/treatment-guidelines\/screening-recommendations.htm (2025)."},{"key":"74025_CR8","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1086\/652395","volume":"201","author":"CL Haggerty","year":"2010","unstructured":"Haggerty, C. L. et al. Risk of sequelae after chlamydia trachomatis genital infection in women. J. Infect. Dis. 201, S134\u2013S155 (2010).","journal-title":"J. Infect. Dis."},{"key":"74025_CR9","doi-asserted-by":"publisher","first-page":"e040789","DOI":"10.1136\/bmjopen-2020-040789","volume":"11","author":"Z Qu","year":"2021","unstructured":"Qu, Z. et al. Effect of screening young men for Chlamydia trachomatis on the rates among women: a network modelling study for high-prevalence communities. BMJ Open 11, e040789 (2021).","journal-title":"BMJ Open"},{"key":"74025_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/sextrans-2021-054992","volume":"97","author":"JEAM van Bergen","year":"2021","unstructured":"van Bergen, J. E. A. M. et al. Where to go to in chlamydia control? From infection control towards infectious disease control. Sex. Transm. Infect. 97, 501\u2013506 (2021).","journal-title":"Sex. Transm. Infect."},{"key":"74025_CR11","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3390\/antibiotics11111634","volume":"11","author":"R Rodrigues","year":"2022","unstructured":"Rodrigues, R., Marques, L., Vieira-Baptista, P., Sousa, C. & Vale, N. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future. Antibiotics 11, 1634 (2022).","journal-title":"Antibiotics"},{"key":"74025_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11904-025-00722-7","volume":"22","author":"L Giacani","year":"2025","unstructured":"Giacani, L. et al. Antimicrobial resistance in curable sexually transmitted infections. Curr. HIV\/AIDS Rep. 22, 14 (2025).","journal-title":"Curr. HIV\/AIDS Rep"},{"key":"74025_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jac\/dky548","volume":"74","author":"FYS Kong","year":"2019","unstructured":"Kong, F. Y. S., Horner, P., Unemo, M. & Hocking, J. S. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J. Antimicrob. Chemother. 74, 1157\u20131166 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"74025_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.epidem.2010.04.002","volume":"2","author":"CL Althaus","year":"2010","unstructured":"Althaus, C. L., Heijne, J. C. M., Roellin, A. & Low, N. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics 2, 123\u2013131 (2010).","journal-title":"Epidemics"},{"key":"74025_CR15","doi-asserted-by":"publisher","first-page":"e4316","DOI":"10.1136\/bmj.e4316","volume":"345","author":"IVF Van Den Broek","year":"2012","unstructured":"Van Den Broek, I. V. F. et al. Effectiveness of yearly, register-based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ. 345, e4316\u2013e4316 (2012).","journal-title":"BMJ"},{"key":"74025_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000542685","volume":"43","author":"E Mata","year":"2024","unstructured":"Mata, E., Ang\u00e9lico-Gon\u00e7alves, A., Leite, A. R. & Queiroz Almeida, D. Unveiling the cost-effectiveness of chlamydia screening strategies: a systematic review. Port. J. Public Health 43, 47\u201358 (2024).","journal-title":"Port. J. Public Health"},{"key":"74025_CR17","doi-asserted-by":"publisher","first-page":"e000345","DOI":"10.1136\/bmjph-2023-000345","volume":"2","author":"M Makhoul","year":"2024","unstructured":"Makhoul, M., Ayoub, H. H., Awad, S. F., Chemaitelly, H. & Abu-Raddad, L. J. Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses. BMJ Public Health 2, e000345 (2024).","journal-title":"BMJ Public Health"},{"key":"74025_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","volume":"19","author":"S Abraham","year":"2019","unstructured":"Abraham, S. et al. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 19, 1091\u20131100 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"74025_CR19","doi-asserted-by":"publisher","first-page":"251513552092388","DOI":"10.1177\/2515135520923887","volume":"8","author":"EDG McIntosh","year":"2020","unstructured":"McIntosh, E. D. G. Development of vaccines against the sexually transmitted infections gonorrhea, syphilis, Chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus. Ther. Adv. Vaccines Immunother. 8, 2515135520923887 (2020).","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"74025_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fmicb.2019.00070","volume":"10","author":"S Phillips","year":"2019","unstructured":"Phillips, S., Quigley, B. L. & Timms, P. Seventy years of chlamydia vaccine research \u2013 limitations of the past and directions for the future. Front. Microbiol. 10, 70 (2019).","journal-title":"Front. Microbiol."},{"key":"74025_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/00005650-198908000-00007","volume":"27","author":"H Buhaug","year":"1989","unstructured":"Buhaug, H., Skjeldestad, F. E., Backe, B. & Dalen, A. Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med. Care 27, 833\u2013841 (1989).","journal-title":"Med. Care"},{"key":"74025_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/OLQ.0000000000000598","volume":"44","author":"MM R\u00f6nn","year":"2017","unstructured":"R\u00f6nn, M. M. et al. The use of mathematical models of chlamydia transmission to address public health policy questions: a systematic review. Sex. Transm. Dis. 44, 278\u2013283 (2017).","journal-title":"Sex. Transm. Dis."},{"key":"74025_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tpb.2014.01.005","volume":"93","author":"DM Vickers","year":"2014","unstructured":"Vickers, D. M. & Osgood, N. D. The arrested immunity hypothesis in an immunoepidemiological model of Chlamydia transmission. Theor. Popul. Biol. 93, 52\u201362 (2014).","journal-title":"Theor. Popul. Biol."},{"key":"74025_CR24","doi-asserted-by":"publisher","first-page":"110291","DOI":"10.1016\/j.jtbi.2020.110291","volume":"497","author":"MD Akinlotan","year":"2020","unstructured":"Akinlotan, M. D., Mallet, D. G. & Araujo, R. P. Mathematical modelling of the role of mucosal vaccine on the within-host dynamics of Chlamydia trachomatis. J. Theor. Biol. 497, 110291 (2020).","journal-title":"J. Theor. Biol."},{"key":"74025_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4682-3-3","volume":"3","author":"KM Turner","year":"2006","unstructured":"Turner, K. M. et al. Developing a realistic sexual network model of chlamydia transmission in Britain. Theor. Biol. Med. Model. 3, 3 (2006).","journal-title":"Theor. Biol. Med. Model."},{"key":"74025_CR26","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1086\/598983","volume":"199","author":"RT Gray","year":"2009","unstructured":"Gray, R. T., Beagley, K. W., Timms, P. & Wilson, D. P. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J. Infect. Dis. 199, 1680\u20131688 (2009).","journal-title":"J. Infect. Dis."},{"key":"74025_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/OLQ.0b013e31824e52c2","volume":"39","author":"M Kretzschmar","year":"2012","unstructured":"Kretzschmar, M., Satterwhite, C., Leichliter, J. & Berman, S. Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study. Sex. Transm. Dis. 39, 325\u2013331 (2012).","journal-title":"Sex. Transm. Dis."},{"key":"74025_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","volume":"20","author":"LM De La Maza","year":"2021","unstructured":"De La Maza, L. M., Darville, T. L. & Pal, S. Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go? Expert Rev. Vaccines 20, 421\u2013435 (2021).","journal-title":"Expert Rev. Vaccines"},{"key":"74025_CR29","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1086\/652400","volume":"201","author":"BE Batteiger","year":"2010","unstructured":"Batteiger, B. E., Xu, F., Johnson, R. E. & Rekart, M. L. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J. Infect. Dis. 201, S178\u2013S189 (2010).","journal-title":"J. Infect. Dis."},{"key":"74025_CR30","doi-asserted-by":"publisher","first-page":"S549","DOI":"10.1093\/infdis\/jiu483","volume":"210","author":"B Davies","year":"2014","unstructured":"Davies, B. et al. Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada. J. Infect. Dis. 210, S549\u2013S555 (2014).","journal-title":"J. Infect. Dis."},{"key":"74025_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20220","volume":"20","author":"M Price","year":"2016","unstructured":"Price, M. et al. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Health Technol. Assess. 20, 1\u2013250 (2016).","journal-title":"Health Technol. Assess."},{"key":"74025_CR32","doi-asserted-by":"publisher","unstructured":"Ghaswalla, P. K. et al. Hepatitis A, B, and A\/B vaccination series completion among US adults: a claims-based analysis. Hum. Vaccines Immunother. 1\u20136 https:\/\/doi.org\/10.1080\/21645515.2018.1489189 (2018).","DOI":"10.1080\/21645515.2018.1489189"},{"key":"74025_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/infdis\/jiw178","volume":"214","author":"MJ Price","year":"2016","unstructured":"Price, M. J. et al. Proportion of pelvic inflammatory disease cases caused by Chlamydia trachomatis: consistent picture from different methods. J. Infect. Dis. 214, 617\u2013624 (2016).","journal-title":"J. Infect. Dis."},{"key":"74025_CR34","first-page":"883","volume":"45","author":"Centers for Disease Control and Prevention (CDC)","year":"1996","unstructured":"Centers for Disease Control and Prevention (CDC) Ten leading nationally notifiable infectious diseases--United States, 1995. MMWR Morb. Mortal. Wkly. Rep. 45, 883\u2013884 (1996).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"74025_CR35","first-page":"63","volume":"5","author":"N Mesbah","year":"2016","unstructured":"Mesbah, N. & Salem, H. K. Genital tract infection as a cause of male infertility. Genit. Infect. Infertil. 5, 63\u201368 (2016).","journal-title":"Genit. Infect. Infertil."},{"key":"74025_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/IJGM.S241099","volume":"ume 13","author":"E Babakhanzadeh","year":"2020","unstructured":"Babakhanzadeh, E., Nazari, M., Ghasemifar, S. & Khodadadian, A. Some of the factors involved in male infertility: a prospective review. Int. J. Gen. Med. ume 13, 29\u201341 (2020).","journal-title":"Int. J. Gen. Med."},{"key":"74025_CR37","unstructured":"Adolescent sexuality in the United States. Wikipedia (2025)."},{"key":"74025_CR38","unstructured":"CDC. Table 32. Chlamydia \u2014 reported cases and rates of reported cases by age group and sex, United States. STI Statistics https:\/\/www.cdc.gov\/sti-statistics\/data-vis\/table-ct-agesex.html (2024)."},{"key":"74025_CR39","unstructured":"Bureau, U. C. age and sex composition in the United States: 2018. Census.gov https:\/\/www.census.gov\/data\/tables\/2018\/demo\/age-and-sex\/2018-age-sex-composition.html."},{"key":"74025_CR40","doi-asserted-by":"crossref","unstructured":"McKeever, N. Is sex work inherently gendered? Hypatia 1\u201320 (2025).","DOI":"10.1017\/hyp.2024.56"},{"key":"74025_CR41","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1093\/cid\/cir697","volume":"53","author":"LM Gorgos","year":"2011","unstructured":"Gorgos, L. M. & Marrazzo, J. M. Sexually transmitted infections among women who have sex with women. Clin. Infect. Dis. 53, S84\u2013S91 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"74025_CR42","unstructured":"Fry, R. A growing share of U.S. husbands and wives are roughly the same age. Pew Research Center https:\/\/www.pewresearch.org\/short-reads\/2024\/08\/15\/a-growing-share-of-us-husbands-and-wives-are-roughly-the-same-age\/ (2024)."},{"key":"74025_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/OLQ.0000000000001382","volume":"48","author":"KM Kreisel","year":"2021","unstructured":"Kreisel, K. M., Weston, E. J., St. Cyr, S. B. & Spicknall, I. H. Estimates of the prevalence and incidence of chlamydia and gonorrhea among US men and women, 2018. Sex. Transm. Dis. 48, 222 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"74025_CR44","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/infdis\/jit094","volume":"207","author":"WM Geisler","year":"2013","unstructured":"Geisler, W. M., Lensing, S. Y., Press, C. G. & Hook, E. W. III Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J. Infect. Dis. 207, 1850\u20131856 (2013).","journal-title":"J. Infect. Dis."},{"key":"74025_CR45","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1086\/652402","volume":"201","author":"WM Geisler","year":"2010","unstructured":"Geisler, W. M. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J. Infect. Dis. 201, S104\u2013S113 (2010).","journal-title":"J. Infect. Dis."},{"key":"74025_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/sextrans-2018-053543","volume":"95","author":"R Omori","year":"2019","unstructured":"Omori, R., Chemaitelly, H., Althaus, C. L. & Abu-Raddad, L. J. Does infection with Chlamydia trachomatis induce long-lasting partial immunity? Insights from mathematical modelling. Sex. Transm. Infect. 95, 115\u2013121 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"74025_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/OLQ.0000000000000412","volume":"43","author":"LF Johnson","year":"2016","unstructured":"Johnson, L. F. & Geffen, N. A comparison of two mathematical modeling frameworks for evaluating sexually transmitted infection epidemiology. Sex. Transm. Dis. 43, 139\u2013146 (2016).","journal-title":"Sex. Transm. Dis."},{"key":"74025_CR48","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1093\/infdis\/jiaa771","volume":"224","author":"KM Kreisel","year":"2021","unstructured":"Kreisel, K. M. et al. The Burden of and trends in pelvic inflammatory disease in the United States, 2006\u20132016. J. Infect. Dis. 224, S103\u2013S112 (2021).","journal-title":"J. Infect. Dis."},{"key":"74025_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1517\/17425247.2.3.549","volume":"2","author":"J Igietseme","year":"2005","unstructured":"Igietseme, J. et al. Delivery of Chlamydia vaccines. Expert Opin. Drug Deliv. 2, 549\u2013562 (2005).","journal-title":"Expert Opin. Drug Deliv"},{"key":"74025_CR50","doi-asserted-by":"publisher","first-page":"e56643","DOI":"10.2196\/56643","volume":"10","author":"BW Bennett","year":"2024","unstructured":"Bennett, B. W. et al. population percentage and population size of men who have sex with men in the United States, 2017-2021: meta-analysis of 5 population-based surveys. JMIR Public Health Surveill 10, e56643 (2024).","journal-title":"JMIR Public Health Surveill"},{"key":"74025_CR51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/14681994.2019.1574970","volume":"34","author":"DA Sawicki","year":"2019","unstructured":"Sawicki, D. A., Meffert, B. N., Read, K. & Heinz, A. J. Culturally competent health care for sex workers: an examination of myths that stigmatize sex work and hinder access to care. Sex. Relatsh. Ther. 34, 355\u2013371 (2019).","journal-title":"Sex. Relatsh. Ther."},{"key":"74025_CR52","unstructured":"U.S.: reported to infidelity 2021. Statista https:\/\/www.statista.com\/statistics\/1367073\/us-reported-to-infidelity\/."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74025-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74025-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74025-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:02:01Z","timestamp":1784772121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74025-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74025"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74025-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VBC, SSC and EWT are employees of Sanofi and may hold shares and\/or stock options. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7099"}}